KATHRYN GRANADOS: Open Payments
NPI 1023762812 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 33 payments from 13 companies in 2025. Trend: 2023 $1,400 · 2024 $1,583 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $130 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Bausch Health US, LLC | 4 | $100 |
| Corium, LLC | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, REXULTI, APLENZIN, Azstarys, Qelbree, Jornay PM, LYBALVI, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
